₹519.4
0.64%
Low
Day's Volatility:6.33%
High
5.69%
52.99%
Low
52 Weeks Volatility:66.75%
High
13.76%
Returns % | |
1 Month Return | 1.63 % |
3 Month Return | 10.01 % |
1 Year Return | 111.63 % |
Market Stats | |
Previous Close | ₹529.50 |
Open | ₹530.05 |
Volume | 37.28K |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹1,101.28Cr |
Organisation | Windlas Biotech Ltd |
Headquarters | Gurgaon |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Windlas Biotech Ltd
Windlas Biotech has commissioned a state-of-the-art injectable facility in Gurugram to manufacture Small Volume Parenteral products, expanding its product portfolio to critical care and other specialized therapeutic segments. The facility meets international cGMP standards and has received a manufacturing license from the Drug Controlling & Licensing Authority of Uttarakhand. Windlas Biotech's shares rose by 0.97% on the BSE.
Windlas Biotech Stock Increases by 34% in Three Months - 08 Mar, 2024
The stock of Windlas Biotech has increased significantly by 34% over the past three months. The company's key financial indicators, particularly ROE, will be assessed to determine its role in the recent price movement.
Fundamentals of Windlas Biotech Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Retail Holding Up
Retail Investor have increased holdings from 24.12% to 24.19% in Mar 2024 quarter
Price Rise
In the last 6 months, WINDLAS stock has moved up by 49.8%
Revenue Rich
Revenue is up for the last 5 quarters, 121.87 Cr → 165.38 Cr (in ₹), with an average increase of 7.2% per quarter
Best in 1 Year
In the last 1 year, WINDLAS has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Profit Spike
Netprofit is up for the last 5 quarters, 9.19 Cr → 15.1 Cr (in ₹), with an average increase of 11.5% per quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 62.82% of holdings in Mar 2024 quarter
FII Holding Down
Foreign Institutions have decreased holdings from 1.35% to 1.18% in Mar 2024 quarter
MF Holding Down
Mutual Funds have decreased holdings from 10.40% to 10.37% in Mar 2024 quarter
Windlas Biotech Ltd in the last 5 years
Lowest (10.46x)
March 28, 2023
Today (21.04x)
April 16, 2024
Industry (60.97x)
April 16, 2024
Highest (23.05x)
March 2, 2024
Funds | Holdings |
ICICI Prudential Smallcap Fund Direct Plan Growth | 0.77% |
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth | 1.16% |
UTI Healthcare Fund-Growth Option- Direct | 1.16% |
Investors | Holdings % | Prev. 1 periods | 3M change |
---|---|---|---|
Promoter Holdings | 62.82% | 0.00 | |
Foreign Institutions | 1.18% | 0.00 | |
Mutual Funds | 10.37% | 0.00 | |
Retail Investors | 24.19% | 0.00 | |
Others | 1.45% | 0.00 |
Technicals of Windlas Biotech Ltd share
News & Events of Windlas Biotech Ltd
Windlas Biotech Ltd (WINDLAS) share price today is ₹519.4
Windlas Biotech Ltd is listed on NSE
Windlas Biotech Ltd is listed on BSE
PE Ratio of Windlas Biotech Ltd is 21.04
PE ratio = Windlas Biotech Ltd Market price per share / Windlas Biotech Ltd Earnings per share
Today’s traded volume of Windlas Biotech Ltd(WINDLAS) is 37.28K.
Today’s market capitalisation of Windlas Biotech Ltd(WINDLAS) is ₹1101.28Cr.
Windlas Biotech Ltd(WINDLAS | Price |
---|---|
52 Week High | ₹590.85 |
52 Week Low | ₹244.15 |
Windlas Biotech Ltd(WINDLAS) share price is ₹519.4. It is down -12.09% from its 52 Week High price of ₹590.85
Windlas Biotech Ltd(WINDLAS) share price is ₹519.4. It is up 112.74% from its 52 Week Low price of ₹244.15
Windlas Biotech Ltd(WINDLAS | Returns |
---|---|
1 Day Returns | -10.1% |
1 Month Returns | 1.63% |
3 Month Returns | 10.01% |
1 Year Returns | 111.63% |